Testing effectiveness (Phase 2)Study completedNCT04380961
What this trial is testing
Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19
Who this might be right for
Critical Confirmed Coronavirus Disease (COVID)-19
Janssen Pharmaceutica N.V., Belgium 212